NO donors, part 8 [1]: Synthesis and vasodilating activities of substituted benzylnitrates compared to cyclohexylmethylnitrate and GTN

European Journal of Medicinal Chemistry

Volumn 38, Issue 6, 2003, Pages 581-586

  Weßler, Christoph ^a   Homann, Alexander ^b   Fricke, Uwe ^b   Lehmann, Jochen ^a,c  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^b UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^c Lehrstuhl fur Pharmazeut/Med Chem   (Germany)

Author keywords

Benzylnitrates; GTN; Nitric oxide; Organic nitrates; Vasodilator potency

Indexed keywords

3 NITRO 4 NITROOXYMETHYLBENZALDEHYDE; 4 NITROBENZYLNITRATE; 4 NITROOXYMETHYLBENZALDEHYDE; 4 NITROOXYMETHYLBENZALDEHYDE ETHYLENACETATE; 4 NITROOXYMETHYLBENZOIC ACID; 4 NITROOXYMETHYLBENZONITRILE; 4 TERT BUTYLBENZYLNITRATE; BENZYLNITRATE; CYCLOHEXYLMETHYLNITRATE; ETHYL 4 NITROOXYMETHYLBENZOIC ACID; GLYCEROLTRINITRATE; NITRIC ACID DERIVATIVE; NITRIC OXIDE DONOR; PROSTAGLANDIN F2 ALPHA; UNCLASSIFIED DRUG; VASODILATOR AGENT;

ANIMAL TISSUE; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CORONARY ARTERY CONSTRICTION; CORONARY ARTERY DILATATION; CORRELATION ANALYSIS; DRUG ACTIVITY; DRUG SYNTHESIS; IN VITRO STUDY; LIPOPHILICITY; NONHUMAN; STRUCTURE ACTIVITY RELATION; SUBSTITUTION REACTION; SWINE;

EID: 0038121759     PISSN: 02235234     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0223-5234(03)00079-5     Document Type: Article

References (15)

1. Kartasasmita R.E., Laufer S., Lehmann J. Arch. Pharm. Pharm. Med. Chem. 335:2002;363-366.
2. Vallence P. J. Clin. Pharmacol. 45:1998;433-439.
3. Bennett B.M., McDonald B.J., James S.T. J. Pharmacol. Exp. Ther. 261:1992;716-723.
4. A. Kleschyov, M. August, A. Mülsch, Th. Münzel, Nitric Oxide (2000) 413.
5. Boschan R., Merrow R.T. Chem. Rev. 55:1955;485-510.
6. Cristol S.J., Leffler J.E. J. Am. Chem. Soc. 76:1954;4468-4469.
7. Kojda G., Beck J.K., Meyer W., Noack E. Br. J. Pharmacol. 112:1994;533-540.
8. Yamashita T., Kawashima S., Ohashi Y., Ozaki M., Rikitake Y., Inoue N., Hirata K., Akita H., Yokoyama M. Hypertension. 36:2000;97-102.
9. Snyder E. J. Am. Chem. Soc. 80:1958;4622-4624.
10. Lehmann J., Kahlich R., Meyer zum Gottesberge C., Fricke U. Arch. Pharm. Pharm. Med. Chem. 330:1997;247-252.
11. Pattison F.L., Brown G.M. Can. J. Chem. 34:1956;879-884.
12. Endres S., Hacker A., Noack E., Kojda G., Lehmann J. Eur. J. Med. Chem. 34:1999;985-991.
13. Baker J.W., Heggs T.G. J. Chem. Soc. 616:1955;623.
14. Schüssler M., Hölzl J., Rump A.F.E., Fricke U. Gen. Pharmacol. 26:1995;1565-1570.
15. Hafner D., Heinen E., Noack E. Arzneimittelforschung. 27:1977;1871-1873.